Cargando…
Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect
PURPOSE: In 2013, Angelina Jolie disclosed in the New York Times (NYT) that she had undergone risk-reducing bilateral mastectomy (RRBM) after learning that she was a BRCA1 mutation carrier. We examined the rates of BRCA testing and RRBM from 1997 to 2016, and quantified trends before and after the J...
Autores principales: | Liede, Alexander, Cai, Mona, Crouter, Tamara Fidler, Niepel, Daniela, Callaghan, Fiona, Evans, D. Gareth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096880/ https://www.ncbi.nlm.nih.gov/pubmed/29808287 http://dx.doi.org/10.1007/s10549-018-4824-9 |
Ejemplares similares
-
The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
por: Grossman, Sharon Galper
Publicado: (2015) -
The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
por: Basu, Narendra Nath, et al.
Publicado: (2021) -
Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women
por: Evans, D. Gareth, et al.
Publicado: (2015) -
Celebrity disclosures and information seeking: The case of Angelina Jolie
por: Juthe, Robin H., et al.
Publicado: (2014) -
Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie’s New York Times editorial
por: Desai, Sunita, et al.
Publicado: (2016)